BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34906154)

  • 1. Multidisciplinary approach to screening and management of children with Fabry disease: practice at a Tertiary Children's Hospital in China.
    Shen Q; Liu J; Chen J; Zhou S; Wang Y; Yu L; Sun L; Wang L; Wu B; Liu F; Cao Y; Huang Y; Wang J; Yang C; Zhu D; Ma Y; Xu Z; Lu W; Fu L; Zhou W; Xu H
    Orphanet J Rare Dis; 2021 Dec; 16(1):509. PubMed ID: 34906154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher rate of rheumatic manifestations and delay in diagnosis in Brazilian Fabry disease patients.
    Rosa Neto NS; Bento JCB; Pereira RMR
    Adv Rheumatol; 2020 Jan; 60(1):7. PubMed ID: 31907047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Ckd. Qld fabRy Epidemiology (aCQuiRE) study protocol: identifying the prevalence of Fabry disease amongst patients with kidney disease in Queensland, Australia.
    Mallett A; Kearey P; Cameron A; Healy H; Denaro C; Thomas M; Lee VW; Stark S; Fuller M; Hoy WE
    BMC Nephrol; 2020 Feb; 21(1):58. PubMed ID: 32087678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of Fabry Disease Screening in Male Pre-End Stage Renal Disease Patients with Unknown Etiology Found Through the Platform of a Chronic Kidney Disease Education Program in a Northern Taiwan Medical Center.
    Lin CJ; Chien YH; Lai TS; Shih HM; Chen YC; Pan CF; Chen HH; Hwu WL; Wu CJ
    Kidney Blood Press Res; 2018; 43(5):1636-1645. PubMed ID: 30380558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Fabry Disease in patients with unexplained left ventricular hypertrophy.
    Sadasivan C; Chow JTY; Sheng B; Chan DKH; Fan Y; Choi PCL; Wong JKT; Tong MMB; Chan TN; Fung E; Kam KKH; Chan JYS; Chi WK; Paterson DI; Senaratne M; Brass N; Oudit GY; Lee APW
    PLoS One; 2020; 15(9):e0239675. PubMed ID: 32987398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expert opinion on the recognition, diagnosis and management of children and adults with Fabry disease: a multidisciplinary Turkey perspective.
    Ezgu F; Alpsoy E; Bicik Bahcebasi Z; Kasapcopur O; Palamar M; Onay H; Ozdemir BH; Topcuoglu MA; Tufekcioglu O
    Orphanet J Rare Dis; 2022 Mar; 17(1):90. PubMed ID: 35236382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fabry disease screening in high-risk populations in Japan: a nationwide study.
    Yoshida S; Kido J; Sawada T; Momosaki K; Sugawara K; Matsumoto S; Endo F; Nakamura K
    Orphanet J Rare Dis; 2020 Aug; 15(1):220. PubMed ID: 32843101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial screening of Fabry disease in patients with hypohidrosis.
    Nagai-Sangawa M; Fukunaga A; Takeuchi C; Nishiyama S; Horikawa T; Nagano C; Nozu K; Fujii H; Nishigori C
    J Dermatol; 2022 Feb; 49(2):308-312. PubMed ID: 34796992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabry disease: Review and experience during newborn screening.
    Hsu TR; Niu DM
    Trends Cardiovasc Med; 2018 May; 28(4):274-281. PubMed ID: 29100912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multidisciplinary treatment in the long-term management of Fabry disease].
    ;
    Zhonghua Nei Ke Za Zhi; 2023 Aug; 62(8):949-955. PubMed ID: 37528032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genotype-phenotype analysis of Fabry disease caused by GLA gene variation in a pedigree].
    Ge ZH; Lu ZH; Pan XD; Lai TT; Yang MJ; Yang HQ; Zhang HB; Li GY; Dai ZQ; Mao JH
    Zhonghua Er Ke Za Zhi; 2024 Mar; 62(4):345-350. PubMed ID: 38527505
    [No Abstract]   [Full Text] [Related]  

  • 12. Newborn genetic screening for Fabry disease: Insights from a retrospective analysis in Nanjing, China.
    Sun Y; Guan XW; Wang YY; Hong DY; Zhang ZL; Li YH; Yang PY; Wang X; Jiang T; Chi X
    Clin Chim Acta; 2024 Apr; 557():117889. PubMed ID: 38531466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy diagnosis improvement of Fabry disease from dried blood spots: Enzyme activity, lyso-Gb3 accumulation and GLA gene sequencing.
    Delarosa-Rodríguez R; Santotoribio JD; Paula HA; González-Meneses A; García-Morillo S; Jiménez-Arriscado P; Guerrero JM; Macher HC
    Clin Genet; 2021 Jun; 99(6):761-771. PubMed ID: 33527381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fabry disease caused by the GLA p.Phe113Leu (p.F113L) variant: Natural history in males.
    Oliveira JP; Nowak A; Barbey F; Torres M; Nunes JP; Teixeira-E-Costa F; Carvalho F; Sampaio S; Tavares I; Pereira O; Soares AL; Carmona C; Cardoso MT; Jurca-Simina IE; Spada M; Ferreira S; Germain DP
    Eur J Med Genet; 2020 Feb; 63(2):103703. PubMed ID: 31200018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice.
    Terryn W; Cochat P; Froissart R; Ortiz A; Pirson Y; Poppe B; Serra A; Van Biesen W; Vanholder R; Wanner C
    Nephrol Dial Transplant; 2013 Mar; 28(3):505-17. PubMed ID: 23234755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prevalence of Fabry Disease in Patients with Chronic Kidney Disease in Turkey: The TURKFAB Study.
    Turkmen K; Guclu A; Sahin G; Kocyigit I; Demirtas L; Erdur FM; Sengül E; Ozkan O; Emre H; Turgut F; Unal H; Karaman M; Acıkel C; Esen H; Balli E; Bıtırgen G; Tonbul HZ; Yılmaz MI; Ortiz A
    Kidney Blood Press Res; 2016; 41(6):1016-1024. PubMed ID: 28006774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and genetic spectrum in Chinese families with Fabry disease: a single-centre case series.
    Chen X; Li H; Liao H; Zhan X; Zhong Z; Zhang Q; Liu L; Liang Y; Deng H; Fang X; Xue Y; Wu S; Liu Y
    ESC Heart Fail; 2021 Dec; 8(6):5436-5444. PubMed ID: 34704396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for Fabry disease in patients undergoing dialysis for chronic renal failure in Turkey: identification of new case with novel mutation.
    Okur I; Ezgu F; Biberoglu G; Tumer L; Erten Y; Isitman M; Eminoglu FT; Hasanoglu A
    Gene; 2013 Sep; 527(1):42-7. PubMed ID: 23756194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management and treatment of children with Fabry disease: A United States-based perspective.
    Hopkin RJ; Jefferies JL; Laney DA; Lawson VH; Mauer M; Taylor MR; Wilcox WR;
    Mol Genet Metab; 2016 Feb; 117(2):104-13. PubMed ID: 26546059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosing lysosomal storage disorders: Fabry disease.
    Bodamer OA; Johnson B; Dajnoki A
    Curr Protoc Hum Genet; 2013; Chapter 17():Unit17.13. PubMed ID: 23595598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.